Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects and mechanisms of Apelin in treating central nervous system diseases. | Neuroscience | 2025 | 39681256 | PubTator, text mining | PubMed |
| Apelin/APJ increased renal blood flow through endothelial BKCa channel induced p-eNOS and ET-1 in diabetic conditions. | Peptides | 2025 | 39644975 | PubTator, text mining | PubMed |
| Silencing APLNR enhances the radiosensitivity of prostate cancer by modulating the PI3K/AKT/mTOR signaling pathway. | Clin Transl Oncol | 2025 | 39251496 | PubTator, text mining | PubMed |
| A Comparison of Apelin Rs56204867 and Apelin Receptor Rs11544374 Gene Polymorphisms and Their Association with Risk of Preeclampsia in Southeast Iran. | Rep Biochem Mol Biol | 2024 | 39995647 | PubTator, text mining | PubMed |
| Apelin/APJ system: a novel promising target for anti-oxidative stress in stroke. | Front Pharmacol | 2024 | 39881878 | PubTator, text mining | PubMed |
| Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications. | Biomedicines | 2024 | 39857634 | PubTator, text mining | PubMed |
| Apelin deficiency exacerbates cardiac injury following infarction by accelerating cardiomyocyte ferroptosis. | Free Radic Res | 2024 | 39731709 | PubTator, text mining | PubMed |
| Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor. | Nat Commun | 2024 | 39730334 | PubTator, text mining | PubMed |
| The future of G protein-coupled receptor therapeutics: Apelin receptor acts as a prototype for the advancement of precision drug design. | Clin Transl Med | 2024 | 39658529 | PubTator, text mining | PubMed |
| Harnessing the power of structure-based design: A new lease on life for cardiovascular drug development with apelin receptor modulators. | Clin Transl Med | 2024 | 39648165 | PubTator, text mining | PubMed |
| Effect of SARS-CoV-2 Infection on Selected Parameters of the Apelinergic System in Repeat Blood Donors. | Biomedicines | 2024 | 39595149 | PubTator, text mining | PubMed |
| Identification of apelin/APJ signaling dysregulation in a human iPSC-derived granulosa cell model of Turner syndrome. | Cell Death Discov | 2024 | 39543104 | PubTator, text mining | PubMed |
| Divergent roles of DRY and NPxxY motifs in selective activation of downstream signalling by the apelin receptor. | Biochem J | 2024 | 39513765 | PubTator, text mining | PubMed |
| Protective effect of apelin-13 in lens epithelial cells via inhibiting oxidative stress-induced apoptosis. | BMC Ophthalmol | 2024 | 39497115 | PubTator, text mining | PubMed |
| Activation of the apelin/APJ system by vitamin D attenuates age-related muscle atrophy. | Life Sci | 2024 | 39488262 | PubTator, text mining | PubMed |
| Potential Involvement of Apelin/APJ System in Addiction and Neuroprotection Against Drugs of Abuse. | Addict Health | 2024 | 39439853 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal apelin/APJ pathway's role in microvessel formation and tumour progression in hepatocellular carcinoma. | J Cell Mol Med | 2024 | 39434201 | PubTator, text mining | PubMed |
| Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control. | Nat Commun | 2024 | 39358374 | PubTator, text mining | PubMed |
| Inflammatory Intracellular Signaling in Neurons Is Influenced by Glial Soluble Factors in iPSC-Based Cell Model of PARK2-Associated Parkinson's Disease. | Int J Mol Sci | 2024 | 39273568 | PubTator, text mining | PubMed |
| The Elabela-APJ axis attenuates sepsis-induced myocardial dysfunction by reducing pyroptosis by balancing the formation and degradation of autophagosomes. | Free Radic Biol Med | 2024 | 39241986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=7